admin01

About Andrew Rivard

This author has not yet filled in any details.
So far Andrew Rivard has created 667 blog entries.

[Approval] Machine perfusion of donor heart with normothermic blood versus hypothermic HTK in preserving coronary endothelium in a porcine model of DCD

Approve this article for publication

Delete this article


Ann Palliat Med. 2020 Jul;9(4):1476-1487. doi: 10.21037/apm-20-131. Epub 2020 Jul 13.

ABSTRACT

BACKGROUND: Both machine perfusion (MP) of donor hearts with autologous blood and crystalloid perfusates have advantages and disadvantages. Currently, which of the aforementioned preservation strategies can better

[Approval] Hypothermic, oxygenated perfusion (HOPE) provides cardioprotection via succinate oxidation prior to normothermic perfusion in a rat model of donation after circulatory death (DCD)

Approve this article for publication

Delete this article


Am J Transplant. 2021 Mar;21(3):1003-1011. doi: 10.1111/ajt.16258. Epub 2020 Sep 15.

ABSTRACT

In donation after circulatory death (DCD), cardiac grafts are subjected to warm ischemia in situ, prior to a brief period of cold, static storage (CSS) at procurement,

[Approval] Comparing Donor Heart Assessment Strategies During Ex Situ Heart Perfusion to Better Estimate Posttransplant Cardiac Function

Approve this article for publication

Delete this article


Transplantation. 2020 Sep;104(9):1890-1898. doi: 10.1097/TP.0000000000003374.

ABSTRACT

BACKGROUND: Ex situ heart perfusion (ESHP) limits ischemic periods and enables continuous monitoring of donated hearts; however, a validated assessment method to predict cardiac performance has yet to be established. We compare biventricular

[Approval] Cold non-ischemic heart preservation with continuous perfusion prevents early graft failure in orthotopic pig-to-baboon xenotransplantation

Approve this article for publication

Delete this article


Xenotransplantation. 2021 Jan;28(1):e12636. doi: 10.1111/xen.12636. Epub 2020 Aug 25.

ABSTRACT

BACKGROUND: Successful preclinical transplantations of porcine hearts into baboon recipients are required before commencing clinical trials. Despite years of research, over half of the orthotopic cardiac xenografts were lost